@article {2438, title = {Visual Mapping and Future Direction of Marine Products Supplementary and Chemotherapy in The Treatment of Breast Cancer. A Bibliometric}, journal = {Pharmacognosy Journal}, volume = {16}, year = {2024}, month = {December 2024}, pages = {1379-1388}, type = {Research Article}, chapter = {1379}, abstract = {

Marine products have gained attention for their potential benefits in the treatment of breast cancer, offering an alternative or supplementary approach to traditional therapies. While they are not intended to replace established medical treatments like chemotherapy or surgery, marine natural products have shown promise in providing symptom relief, enhancing the quality of life, and potentially improving treatment success for breast cancer patients. Studies have explored the use of marine products in conjunction with chemotherapy for their palliative care benefits and as adjuvants to conventional therapies. Marinederived compounds have been investigated for their anticancer properties, including apoptosis induction, anti-proliferative effects, and modulation of signaling pathways involved in breast cancer progression. These natural products offer a complementary avenue for managing breast cancer, potentially enhancing treatment outcomes, and addressing therapeutic challenges. The utilization of marine products in breast cancer therapy dates back to ancient times when various cultures recognized the therapeutic benefits of plants, herbs, and marine resources. The purpose of this study is to visually map and guide future research on supplementary marine products and chemotherapy in breast cancer based on bibliometric analysis

}, keywords = {Anticancer, Bibliometric, Breast cancer, Chemotherapy, Marine products, Visual mapping}, doi = {10.5530/pj.2024.16.222}, author = {Herin Setianingsih and Nasywa Zahra Sajida Tsuroyya and Prawesty Diah Utami and Riami and Nanang Wiyono} } @article {686, title = {In vivo Antibacterial Activity of Green Algae Ulva reticulata against Staphylococcus aureus in Drosophila Model of Infection}, journal = {Pharmacognosy Journal}, volume = {10}, year = {2018}, month = {August 2018}, pages = {993-997}, type = {Original Article}, chapter = {993}, abstract = {

Background: Expansion of multi-drug resistant bacteria in social communities and health facilities has been widely reported. To overcome this ever-growing problem, new antibiotics with novel mechanisms of action are urgently required. Purpose: This research was carried out aiming to investigate the in vivo antibacterial effect of green algae Ulva reticulata against Staphylococcus aureus in fruit flies (Drosophila melanogaster) model of infection. Methods: Sample was dried and extracted with ethanol using maceration method. Wild type and mutant fruit flies were infected with S. aureus and subjected to survival and bacterial load analysis in the presence or absence of tetracycline or Ulva reticulata extract at different concentrations. All data were statistically analyzed. Results: Infection of D. melanogaster with S. aureus was characterized by two notable trends: reduction of host survival and increasing level of bacterial growth in the host during the course of infection. Such events were further augmented in mutant flies lacking normal immune responses. Nonetheless, improved survival rates and reduction of bacterial load were observed in wild type and immunodeficient mutant flies challenged with S. aureus in the presence of either tetracycline or ethanolic extracts of green algae Ulva reticulata. Conclusion: Taken together, our results suggest that Ulva reticulata yielded antistaphylococcal activity in vivo thus would be a prospective source for harvesting wide spectrum antibacterial compounds.

}, keywords = {Antistaphylococcal, Drug discovery, Fruit flies, Infection model, Marine products}, doi = {10.5530/pj.2018.5.169}, author = {Firzan Nainu and Rangga Meidianto Asri and Aryadi Arsyad and Marianti Anggreni Manggau and Muhammad Nur Amir} }